tradingkey.logo

Globus Medical Inc

GMED
87.810USD
+0.310+0.35%
Close 02/06, 16:00ETQuotes delayed by 15 min
11.82BMarket Cap
28.09P/E TTM

Globus Medical Inc

87.810
+0.310+0.35%

More Details of Globus Medical Inc Company

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery techniques. It includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

Globus Medical Inc Info

Ticker SymbolGMED
Company nameGlobus Medical Inc
IPO dateMar 08, 2012
CEOPfeil (Keith W)
Number of employees5300
Security typeOrdinary Share
Fiscal year-endMar 08
Address2560 General Armistead Ave
CityAUDUBON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code19403
Phone16109301800
Websitehttps://www.globusmedical.com/
Ticker SymbolGMED
IPO dateMar 08, 2012
CEOPfeil (Keith W)

Company Executives of Globus Medical Inc

Name
Name/Position
Position
Shareholding
Change
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
--
Mr. David C. Paul
Mr. David C. Paul
Executive Chairman of the Board
Executive Chairman of the Board
34.38K
+34375.00%
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
15.38K
-10000.00%
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
10.42K
-2000.00%
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Daniel T. (Dan) Lemaitre
Mr. Daniel T. (Dan) Lemaitre
Independent Director
Independent Director
--
-10800.00%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Director
Independent Director
--
--
Mr. Stephen T. (Steve) Zarrilli
Mr. Stephen T. (Steve) Zarrilli
Independent Director
Independent Director
--
--
Mr. Keith W. Pfeil
Mr. Keith W. Pfeil
President, Chief Executive Officer
President, Chief Executive Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
--
Mr. David C. Paul
Mr. David C. Paul
Executive Chairman of the Board
Executive Chairman of the Board
34.38K
+34375.00%
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
15.38K
-10000.00%
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
10.42K
-2000.00%
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Musculoskeletal Solutions
741.01M
96.35%
Enabling Technologies
28.04M
3.65%
By RegionUSD
Name
Revenue
Proportion
United States
617.63M
80.31%
International
151.41M
19.69%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Musculoskeletal Solutions
741.01M
96.35%
Enabling Technologies
28.04M
3.65%

Shareholding Stats

Updated: Wed, Feb 4
Updated: Wed, Feb 4
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.44%
BlackRock Institutional Trust Company, N.A.
8.68%
Janus Henderson Investors
6.78%
Sculptor Capital Management, Inc
3.14%
State Street Investment Management (US)
3.11%
Other
68.84%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.44%
BlackRock Institutional Trust Company, N.A.
8.68%
Janus Henderson Investors
6.78%
Sculptor Capital Management, Inc
3.14%
State Street Investment Management (US)
3.11%
Other
68.84%
Shareholder Types
Shareholders
Proportion
Investment Advisor
52.03%
Investment Advisor/Hedge Fund
35.92%
Hedge Fund
12.32%
Research Firm
2.10%
Pension Fund
1.90%
Sovereign Wealth Fund
1.09%
Bank and Trust
0.73%
Individual Investor
0.71%
Family Office
0.40%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
1054
118.67M
106.51%
-10.65M
2025Q3
1029
117.81M
104.61%
-7.42M
2025Q2
1034
115.30M
102.09%
-12.49M
2025Q1
1057
115.54M
102.35%
-11.15M
2024Q4
1031
113.94M
83.15%
-12.71M
2024Q3
978
112.33M
98.84%
-21.04M
2024Q2
969
117.21M
103.71%
-15.66M
2024Q1
950
117.87M
104.30%
-9.50M
2023Q4
917
111.19M
96.81%
-13.25M
2023Q3
911
113.44M
96.67%
+12.22M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
10.58M
9.5%
-104.01K
-0.97%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
9.67M
8.68%
-138.27K
-1.41%
Sep 30, 2025
Janus Henderson Investors
7.55M
6.78%
-654.26K
-7.97%
Sep 30, 2025
Sculptor Capital Management, Inc
3.50M
3.14%
+739.31K
+26.78%
Sep 30, 2025
State Street Investment Management (US)
3.46M
3.11%
-11.77K
-0.34%
Sep 30, 2025
Burgundy Asset Management Ltd.
3.46M
3.11%
-20.45K
-0.59%
Sep 30, 2025
JP Morgan Asset Management
3.44M
3.08%
+281.69K
+8.93%
Sep 30, 2025
William Blair Investment Management, LLC
2.82M
2.53%
+414.13K
+17.22%
Sep 30, 2025
Madison Avenue Partners LP
2.55M
2.29%
+836.01K
+48.83%
Sep 30, 2025
Geneva Capital Management LLC
2.08M
1.87%
+1.15K
+0.06%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
2.96%
First Trust Indxx Medical Devices ETF
2.14%
First Trust Health Care Alphadex Fund
1.84%
State Street SPDR S&P Health Care Equipment ETF
1.84%
ROBO Global Healthcare Technology & Innovation ETF
1.33%
Invesco S&P MidCap 400 Pure Growth ETF
1.32%
ROBO Global Robotics and Automation Index ETF
1.2%
Global X Guru Index ETF
1.2%
ALPS Disruptive Technologies ETF
0.99%
Pacer US Cash Cows Growth ETF
0.97%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion2.96%
First Trust Indxx Medical Devices ETF
Proportion2.14%
First Trust Health Care Alphadex Fund
Proportion1.84%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.84%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.33%
Invesco S&P MidCap 400 Pure Growth ETF
Proportion1.32%
ROBO Global Robotics and Automation Index ETF
Proportion1.2%
Global X Guru Index ETF
Proportion1.2%
ALPS Disruptive Technologies ETF
Proportion0.99%
Pacer US Cash Cows Growth ETF
Proportion0.97%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI